Chulalongkorn Drug Discovery and Drug Development Research Center (Chula4DR) was established in July 2017 under the Chulalongkorn University Research and Innovation Division to facilitate drug discovery and drug development research, advance innovative sciences and create highly skilled researchers in Thailand. As such, Chula4DR aims to transform basic research into innovative research programs with translational value and/or commercial potential, using high–end research and to integrate this with industry–like processes and platforms.
- Track I: Discovery of new compounds starting from ‘Hits’ working up to a ‘Preclinical candidate’ or Clinical Phase I.
- Track II: Development of new drug products (e.g. new dosage form or new delivery system, new route of administration, new strength, etc.) from previously approved drug substances.
1) Core units equipped with essential core capabilities and full–time staff with industry experience and/or excellent scientific track records:
- Medicinal Chemistry
2) Satellite units selected from existing Center of Excellence (CE) or Research Unit (RU), primarily within (but not limited to) Chulalongkorn University, to supplement the above core units with necessary or ancillary capabilities and capacity, on a need basis.
Chula4DR will work in close partnership with other academic and research institutions, relevant government agencies (including regulatory and granting agencies) and private sectors, when possible.
Office of Research Affairs Chulalongkorn University, Chamchuri 5 Bld. 6th Fl.,
Phayathai Rd.,Wangmai, Pathumwan Bangkok 10330
E- Mail: firstname.lastname@example.org